Atomic force microscopy fishing and mass spectrometry identification of gp120 on immobilized aptamers

Atomic force microscopy fishing and mass spectrometry identification of gp120 on immobilized aptamers

Yuri D Ivanov,1 Natalia S Bukharina,1 Tatyana O Pleshakova,1 Pavel A Frantsuzov,1 Elena Yu Andreeva,1 Anna L Kaysheva,1,2 Victor G Zgoda,1 Alexander A Izotov,1 Tatyana I Pavlova,1 Vadim S Ziborov,1 Sergey P Radko,1 Sergei A Moshkovskii,1 Alexander I Archakov1 1Department of Personalized Medicine, O...

Full description

Bibliographic Details
Main Authors:	Ivanov YD, Bukharina NS, Pleshakova TO, Frantsuzov PA, Andreeva EY, Kaysheva AL, Zgoda VG, Izotov AA, Pavlova TI, Ziborov VS, Radko SP, Moshkovskii SA, Archakov AI
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-10-01
Series:	International Journal of Nanomedicine
Online Access:	http://www.dovepress.com/atomic-force-microscopy-fishing-and-mass-spectrometry-identification-o-peer-reviewed-article-IJN

Similar Items

Characterization of RNA aptamers that bind to HIV-1 gp120
by: Cohen, C
Published: (2006)

Detection of Hepatitis C Virus Core Protein in Serum Using Aptamer-Functionalized AFM Chips
by: Tatyana O. Pleshakova, et al.
Published: (2019-02-01)

Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1
by: Dey, AK, et al.
Published: (2005)

HIV-1 subtype C primary isolates exhibit high sensitivity to an anti-gp120 RNA aptamer
by: Mufhandu HT, et al.
Published: (2012-09-01)

Structural characterization of a 2'F-RNA aptamer that binds a HIV-1 SU glycoprotein, gp120.
by: Sayer, N, et al.
Published: (2002)

An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site
by: Cohen, C, et al.
Published: (2008)

An aptamer that neutralizes R5 strains of human immunodeficiency virus type 1 blocks gp120-CCR5 interaction.
by: Dey, A, et al.
Published: (2005)

HIV-1 subtype C unproductively infects human cardiomyocytes in vitro and induces apoptosis mitigated by an anti-Gp120 aptamer.
by: Walter R Lopes de Campos, et al.
Published: (2014-01-01)

Evaluation of Aptamers as Affinity Reagents for an Enhancement of SRM-Based Detection of Low-Abundance Proteins in Blood Plasma
by: Sergey Radko, et al.
Published: (2020-05-01)

Characterization of gp120 and Its Single-chain Derivatives, gp120-CD4 and gp120-M9: Implications for Targeting the CD4i Epitope in HIV-1 Vaccine Design
by: Shiver John
Published: (2005-12-01)

Selection of Aptamers for Use as Molecular Probes in AFM Detection of Proteins
by: Maria O. Ershova, et al.
Published: (2023-12-01)

Physiological Corticosterone Attenuates gp120-Mediated Microglial Activation and Is Associated with Reduced Anxiety-Like Behavior in gp120-Expressing Mice
by: Emaya M. Moss, et al.
Published: (2023-02-01)

Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers.
by: Khati, M, et al.
Published: (2003)

Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity.
by: Heidi E Drummer, et al.
Published: (2013-01-01)

Immuno-MALDI MS dataset for improved detection of HCVcoreAg in sera
by: Anna L. Kaysheva, et al.
Published: (2019-08-01)

Mass Spectrometric Identification of Proteins Enhanced by the Atomic Force Microscopy Immobilization Surface
by: Anna L. Kaysheva, et al.
Published: (2021-01-01)

Atomic Force Microscopy Study of Protein–Protein Interactions in the Cytochrome CYP11A1 (P450scc)-Containing Steroid Hydroxylase System
by: Zöllner A, et al.
Published: (2011-01-01)

Monoclonal antibodies to HIV-1 gp120: a request.
by: Moore, J, et al.
Published: (1993)

STRUCTURAL-ANALYSIS OF THE HIV-1 ENVELOPE GLYCOPROTEIN GP120
by: Moore, J, et al.
Published: (1993)

Behavioral Evidence for a Tau and HIV-gp120 Interaction
by: Murali Vijayan, et al.
Published: (2022-05-01)

NMR spectroscopy of HIV-1 gp120 outer domain
by: Sastry M, et al.
Published: (2012-09-01)

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.
by: Moore, J, et al.
Published: (1995)

Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41
by: Caffrey Michael, et al.
Published: (2004-03-01)

Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.
by: Sunil K Khattar, et al.
Published: (2013-01-01)

Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response
by: Hioe Catarina E, et al.
Published: (2008-07-01)

Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity.
by: Leen Mathys, et al.
Published: (2014-01-01)

Correction: Deletion of the Highly Conserved -Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity.
Published: (2014-01-01)

Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
by: Esser, M, et al.
Published: (1999)

SOLUBLE CD4 BINDING TO HIV-1 VIRIONS CAUSES GP120 TO DISSOCIATE FROM GP41
by: Moore, J, et al.
Published: (1991)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
Published: (2014-01-01)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector.
by: Sunil K. Khattar, et al.
Published: (2014-01-01)

Retraction: Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector.
by: PLOS ONE Editors
Published: (2020-01-01)

HIV gp120: double lock strategy foils host defences.
by: Sattentau, Q
Published: (1998)

Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists
by: Francesca Curreli, et al.
Published: (2022-12-01)

Recent Advances in the Molecular and Cellular Mechanisms of gp120-Mediated Neurotoxicity
by: Valeria Avdoshina, et al.
Published: (2022-05-01)

Structural plasticity and conformational transitions of HIV envelope glycoprotein gp120.
by: Anil Korkut, et al.
Published: (2012-01-01)

Helix-A peptide prevents gp120-mediated neuronal loss
by: Valeria Avdoshina, et al.
Published: (2019-06-01)

HLA-C increases HIV-1 infectivity and is associated with gp120
by: Beretta Alberto, et al.
Published: (2008-08-01)

Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate.
by: Elizabeth Stansell, et al.
Published: (2015-01-01)

Correction: Deletion of the Highly Conserved N-Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity
Published: (2014-01-01)